Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons. by Natera-Naranjo, O. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/88234
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
REPORT
Identification and quantitative analyses of microRNAs
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ABSTRACT
microRNAs (miRNAs) constitute a novel class of small, noncoding RNAs that act as negative post-transcriptional regulators of
gene expression. Although the nervous system is a prominent site of miRNA expression, little is known about the spatial
expression profiles of miRNAs in neurons. Here, we employed compartmentalized Campenot cell culture chambers to obtain a
pure axonal RNA fraction of superior cervical ganglia (SCG) neurons, and determined the miRNA expression levels in these
subcellular structural domains by microarray analysis and by real-time reverse-transcription polymerase chain reaction. The
data revealed stable expression of a number of mature miRNAs that were enriched in the axons and presynaptic nerve terminals.
Among the 130 miRNAs identified in the axon, miR-15b, miR-16, miR-204, and miR-221 were found to be highly abundant in
distal axons as compared with the cell bodies of primary sympathetic neurons. Moreover, a number of miRNAs encoded by a
common primary transcript (pri-miRNA) were differentially expressed in the distal axons, suggesting that there is a differential
subcellular transport of miRNAs derived from the same coding region of the genome. Taken together, the data provide an
important resource for future studies on the regulation of axonal protein synthesis and the role played by miRNAs in the
maintenance of axonal structure and function as well as neuronal growth and development.
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INTRODUCTION
Subcellular mRNA localization comprises a fundamental
mechanism for regulated gene expression in developing and
adult brain. The resulting temporal and spatial patterns
of local protein synthesis is required for a number of im-
portant neuronal processes, such as differentiation and
maturation, axon guidance, synapse formation, and cogni-
tive brain functions (Costa-Mattioli et al. 2009). Previous
studies identified that local translation is under tight con-
trol via a number of different mechanisms, such as control
of mRNA stability (Smart et al. 2007), translation initiation
(Klann et al. 2004), and elongation (Huang et al. 2005) and
by the recently discovered noncoding miRNAs (for review,
see Schratt 2009a). At present, there is little knowledge of
the intricate nature and role played by miRNAs in the
axons and synaptic terminals of neurons. The regulation of
gene expression by miRNAs represents a distinct mecha-
nism of translation regulation. miRNAs are single-stranded
RNA moieties of about 21–23 nucleotides (nt) in length.
They are highly conserved and involved in a subset of
biological processes in which they have been shown to be
implicated in developmental timing, cell proliferation, apo-
ptosis, metabolism, cell differentiation, and morphogenesis
(Ambros and Lee 2004; Niwa and Slack 2007). Several
recent reviews provide detailed descriptions of miRNA
biogenesis and mode of action (Kim 2005; Filipowicz
et al. 2008). Remarkably, it has been shown that these
small molecules coordinately regulate multiple genes cod-
ing for proteins with related cellular functions (van Rooij
and Olson 2007), and their presence in the dendrites of
neurons has been previously reported (Kye et al. 2007;
Lugli et al. 2008; Siegel et al. 2009).
The functions of individual miRNAs in neurons are just
beginning to emerge, and multiple lines of evidence point
to the widespread involvement of miRNAs in various neu-
rological diseases (for review, see Bassell and Warren 2008;
Hunsberger et al. 2009). In addition, recent studies have
elucidated several roles for neural miRNAs at various stages
of synaptic development, including dendritogenesis, synapse
formation, and synapse maturation. Furthermore, some of
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these studies have shown that miRNAs regulate mRNA
translation locally in the synaptodendritic compartment
(for review, see Schratt 2009b). In recent studies, we de-
lineated a novel molecular mechanism by which the brain-
specific miR-338 participated in the regulation of axonal
growth and function by locally modulating the levels of a
nuclear-encoded mitochondrial protein. This finding points
to a novel mechanism for a soma-independent regulation of
protein synthesis in distal axons through neuronal miRNAs
(Aschrafi et al. 2008).
In the present study, we employed a compartmentalized
cell culture system to obtain a pure axonal RNA fraction of
superior cervical ganglia (SCG) neurons, and present the
results of a microarray analysis that led to the identification
of a large heterogeneous population of axonal miRNAs. By
combining microarray expression profiling with miRNA-
specific real-time reverse-transcription polymerase chain
reaction (RT-PCR), we provide, for the first time, a com-
prehensive list of miRNAs residing within the axonal
domain. These data provide a base for future studies of
individual miRNAs, their target genes, and the role played
by the miRNAs in the regulation of local protein synthesis.
RESULTS AND DISCUSSION
Although we routinely monitor the side compartments of
the Campenot cell culture chambers for the presence of
neuronal cell soma and non-neuronal cells using light mi-
croscopy, trace cellular contamination of the axonal RNA
preparation might still be detectable at the level of res-
olution afforded by microarray analysis or real-time PCR
methodology. To address this issue, the purity of the RNA
samples prepared from the distal axons was assessed by
real-time PCR using gene-specific primer sets for mRNAs
present in neuronal cell soma and glia. As shown in Figure
1A, amplicons for munc18, rim, and synapsin 3, mRNAs
encoding proteins involved in synaptic vesicle function,
were readily visualized in RNA prepared from the neurons
present in the central compartment, but were not observed
in RNA obtained from distal axons. Identical results were
obtained using gene-specific primers for glial fibrillary
acidic protein (Fig. 1A, GFAP). These data support the
contention that the RNA prepared from the side compart-
ments is free of neuronal and glial contamination.
Results of Western blot analysis performed on protein
lysates obtained from the side and central compartments of
the Campenot chambers indicate that the distal axonal
fraction is enriched for axonal proteins (Fig. 1B). For ex-
ample, the abundance of Tau, an axonal marker protein,
relative to b-actin, was greater in the distal axons as com-
pared with the neuronal soma (relative ratio axon to soma
4:1). In contrast, distal axons were devoid of MAP2, whereas
this dendritic biomarker was readily detected in protein
samples obtained from the central compartment (Fig. 1B).
Previously, we identified an axonally localized miRNA
that regulates the expression of cytochrome c oxidase IV
(COXIV), a key protein within the electron transfer chain
in mitochondria, which participates in the control of ATP
levels in the axons of sympathetic neurons (Li et al. 2006;
Aschrafi et al. 2008). We reasoned that miRNAs that are
important for axonal function and development might be
located in distal axons, where they could locally regulate the
translation of relevant target mRNAs. To investigate the
global expression of miRNAs in the axons of primary SCG
neurons, we isolated total RNA from the distal axons of
SCG neurons, and delineated the component miRNAs
using a miRNA microarray kit with optimized probe se-
quences targeting all of the known mature rat miRNAs in
the miRBase Sequence Database, Release 9.0. In addition,
we analyzed total RNA from the central compartments of
these cultures, which contained the parental cell bodies and
proximal axons of these neurons. Microarray expression
profiling revealed that axons of rat sympathetic neurons
contain a large, heterogeneous population of miRNAs
(Supplemental Table S1): Several of
these miRNAs are highly expressed in
these neurons. A listing of miRNAs that
are most abundant and/or enriched
in the axon is provided in Table 1. In
addition, the microarray data demon-
strated that miRNAs belonging to the
same family could be readily differenti-
ated by this experimental approach. For
example, miR-125a and miR-125b differ
only by three nucleotides, but yielded
highly reliable and markedly different
signal intensities of 41.2 (65.2 SEM)
and 322.5 (643.8 SEM) relative fluores-
cence units (RFU), respectively.
To further assess the distribution of
the miRNAs in the axons as compared
with cell bodies, we calculated the ratios
FIGURE 1. RNA prepared from the distal axons of SCG neurons is free of neuronal and glial
contamination. (A) RT-PCR analysis was conducted on RNA obtained from the lateral and
central compartments of the Campenot cell culture chambers using gene-specific primer sets
for synaptic vesicle proteins, munc18, rim, synapsin 3 (syn 3), and glial fibrillary acidic protein
(GFAP). PCR products were fractionated on 2.5% agarose gels and amplicons visualized by
ethidium bromide staining. (A) Axon; (S) soma; (bp) base pairs. (B) Protein lysates obtained
from the lateral and central compartments of the Campenot chambers were analyzed by
Western blot using antibodies against Tau and MAP2. Levels of b-actin immunoreactivity
served as an internal control.
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of the axonal signal intensities compared with the signal
intensities in the cell body for each miRNA. The distribu-
tion pattern for 60 miRNAs is shown in Figure 2A. The
average ratio (axon/soma) obtained for the miRNAs by
microarray profiling was 1.26 (60.08 SEM), suggesting that
most miRNAs have similar relative abundances between
the cell bodies and distal axons. However, a number of
miRNAs were observed that were significantly enriched in
the axons compared with the cell bodies, while others were
enriched or present only in the cell bodies. For example,
miR-204, miR-221, miR-15b, and miR-16 are characterized
by the former pattern, while miR-297, miR-206, and miR-
124a are examples of the latter pattern. This finding con-
firmed previous studies reporting that miR-124a, a miRNA
important for neuronal differentiation, is cell-body re-
stricted, as assessed by microarray analysis, in situ hybrid-
ization (ISH), and RT-PCR (Kye et al. 2007; Siegel et al.
2009).
To validate the microarray analysis, we assessed the
expression of 57 miRNAs by real-time quantitative RT-
PCR (qRT-PCR) using miRNA-specific primers. As se-
lection criteria, we chose miRNAs found to be highly
expressed by microarray, with axonal signal intensities that
were three standard deviations above the background
intensity, as well as some that were expressed at a lower
level, with signal intensities that were one to two standard
deviations above background. In addition, 17 miRNAs with
microarray intensities less than one standard deviation
above background level were assayed by qPCR to establish
a cutoff CT value. Previously, it was shown that mature
miRNAs present in low copy number have CT values higher
than 35 (Schmittgen et al. 2008). Consistent with this
finding, the CT values obtained for 16 of these miRNAs
were higher than 36, and the corre-
sponding standard deviations were high
($1). Additionally, melting curve anal-
yses of the amplicons revealed a lack
of fidelity of the signal. A rank ordering
of the 15 most abundant miRNAs, as
judged by qRT-PCR analysis (CT values),
is provided in Table 2.
Following the establishment of the
cutoff CT value, we calculated the rela-
tive expression (RQ) of the miRNAs in
the axons compared with the soma using
the comparative CT method (Schmittgen
and Livak 2008). This method has been
successfully employed in the quantitative
analyses of miRNA expression by real-
time PCR (Saba et al. 2008; Schmittgen
et al. 2008; Aldrich et al. 2009; He´bert
et al. 2009). Briefly, DCT values for each
miRNA were obtained after normalizing
to U6 snRNA, a common normalizer for
miRNA expression, and miR-103, which
has been previously shown to be a very stable reference
miRNA (Peltier and Latham 2008). The RQ for each miRNA
in the axon compared with the soma was calculated using
the equation 2DDCT, where DDCT = DCT,axon DCT,soma
(for example, see Table 2). As shown in Figure 2B, the
analyzed miRNAs were distributed between cell bodies and
axons in a Gaussian fashion similar to the distribution
calculated for miRNAs identified using microarray profiling.
These studies further revealed a high correlation between the
microarray profiling data and the results of real-time RT-
PCR for more than 80% of the miRNAs (r = 0.73, P <
0.0001). Consistent with the microarray results, the average
relative abundance of axonal/somal miRNA obtained by
real-time RT-PCR analysis was 1.2(60.1 SEM)-fold. More-
over, we were able to confirm the axonal enrichment of
miR-204, miR-221, miR-15b, and miR-16 and the cell body
enrichment of miR-297, miR-206, and miR-124a. However,
in a few cases, inconsistencies between the microarray data
and the real-time RT-PCR results were identified. For
example, miR-329 showed a 2.6-fold axonal enrichment
by real-time RT-PCR, but the ratio of intensities (axon/
soma) obtained by microarray was 0.48(60.04 SEM).
Reasons for these discrepancies in the data are unclear,
but could derive from differences in hybridization efficien-
cies or variations in RNA sampling.
To confirm the axonal localization of relatively abundant
miRNAs identified by both microarray and qRT-PCR
analyses, we performed ISH in primary SCG neurons,
using locked nucleic acid (LNA) probes for miR-16, miR-
221, and a scrambled miR probe as a negative control.
Consistent with the microarray and real-time qPCR results,
miR-16 and miR-221 were readily visualized in distal axons
as punctate fluorescent ISH signals (Fig. 3A,B). In contrast,
TABLE 1. List of select relatively abundant or enriched axonal miRNAs as assessed by
microarray analysisa
miRNA
name
Axon
intensity
Soma
intensity
Ratio
of intensities
(axon/soma)
rno-miR-125b 322.50 6 43.75 247.67 6 42.67 1.35 6 0.15
rno-miR-382 132.33 6 9.83 165.17 6 14.49 0.85 6 0.12
rno-miR-23a 126.17 6 11.70 97.17 6 11.49 1.33 6 0.12
rno-miR-23b 125.67 6 3.91 108.50 6 10.98 1.16 6 0.12
rno-miR-24 83.50 6 9.30 106.83 6 18.77 0.84 6 0.11
rno-miR-329 43.00 6 4.57 95.50 6 15.66 0.48 6 0.04
rno-miR-26a 41.67 6 2.63 33.83 6 2.48 1.24 6 0.06
rno-miR-221 41.17 6 4.50 7.17 6 0.83 5.83 6 0.49
rno-miR-16 34.33 6 1.86 9.83 6 3.13 3.69 6 0.35
rno-miR-185 33.67 6 0.67 55.83 6 5.18 0.62 6 0.05
rno-miR-103 32.50 6 2.14 18.33 6 1.33 1.81 6 0.15
rno-miR-127 31.33 6 3.17 23.00 6 3.81 1.44 6 0.15
rno-miR-320 31.17 6 2.02 14.33 6 1.65 2.29 6 0.24
rno-miR-541 27.67 6 1.99 20.33 6 2.74 1.49 6 0.21
Enriched miRNAs manifest axon/soma intensity ratios >1.0.
aMicroarray data are shown as average of six replicates (6SEM).
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no punctate fluorescent signals were observed with the
scrambled miR probe (Fig. 3C).
An essential requirement for the functional role of
miRNAs at post- or presynaptic endings is the targeted
delivery of these noncoding RNAs along the neuronal
processes. However, the mechanism of miRNA transport
is entirely unknown. Several models were proposed for the
shuttling of miRNAs to the synapse (Kosik 2006). The
models proposed included codelivery of miRNAs with their
cognate mRNA targets into neuronal endings by RNA
granules, mRNA-independent delivery of mature miRNAs,
as well as synaptic delivery of the precursor miRNA mol-
ecules, followed by a subsequent local processing by Dicer
to the mature functional miRNA form. The latter model
is supported by our previous findings of the presence of
miRNA processing machinery in distal axons of sympa-
thetic neurons (Aschrafi et al. 2008).
Many of the known miRNAs appear in clusters on a
single polycistronic transcript (Lagos-Quintana et al. 2003).
Although post-transcriptional regulation of miRNA expres-
sion has been demonstrated (Obernosterer et al. 2006),
little is known about the regulation and processing of dif-
ferent miRNAs derived from the same transcript. In this
study, we explored the relative distribution of miRNAs
derived from 13 polycistronic transcripts. Our results indi-
cate that the relative abundance of some of the miRNAs
derived from five polycistronic gene transcripts differed
significantly in the axon and cell soma (Table 3). This find-
ing suggests that only a subset of polycistronically expressed
miRNAs are post-transcriptionally regulated and differen-
tially transported into the distal axons. Alternatively, the
half-lives of these miRNAs might differ markedly in the
two cell compartments. Whether the selective expression of
polycistronically expressed miRNAs is an axon-specific
phenomenon or is manifest in the dendrites is unclear,
and represents an interesting question for future research.
miRNAs fine-tune the expression of their target genes in
disperse locations within the cell. A particularly powerful
aspect of miRNA function is the ability of individual
miRNAs to coordinately regulate a multitude of genes
coding for proteins with related cellular functions. Based
upon this observation, we explored the possibility that
miRNAs that were highly abundant or enriched in the axon
had putative target genes with similar axonal functions.
Using the miRNA target prediction tool TargetScan (Lewis
et al. 2005), we identified putative targets for miR-204,
miR-221, miR-146, miR-16 and miR-15b, miR-320, miR-
103, miR-541, miR-125b, miR-23a and miR-23b, miR-26a,
FIGURE 2. A comparison of the abundance ratios (axon/soma) of
miRNAs expressed in axons as judged by microarray analysis and
qRT-PCR. (A) miRNA expression in the axons assessed by micro-
array. The average ratios of axonal miRNA intensities relative to
miRNA intensity in the soma were calculated for 60 miRNAs. Error
bars represent the standard error of mean (SEM) of six replicates. (B)
miRNA expression in the axons assessed by real-time RT-PCR.
Distribution plot shows the relative expression of axonal miRNAs
compared with the soma as measured using miRNA-specific primers.
Relative expression was calculated using the 2DDCT value after nor-
malizing the CT values in the axons and soma to the corresponding
levels of U6 snRNA. The distribution can be approximated as normal
by means of the Shapiro-Wilk normality test (P = 0.286).
TABLE 2. Abundance rank ordering of axonal miRNAs as assessed
by qRT-PCR analysis
miRNA name
Average CT
a Relative
expression
(2DDCT)bAxon Soma
rno-miR-23b 25.04 6 0.08 20.05 6 0.18 1.46 6 0.07
rno-miR-125b 27.13 6 0.20 21.12 6 0.14 0.72 6 0.07
rno-miR-23a 27.79 6 0.12 22.69 6 0.07 2.12 6 0.11
rno-miR-329 28.37 6 0.16 24.20 6 0.04 2.60 6 0.20
rno-miR-24 28.60 6 0.55 21.75 6 0.04 0.79 6 0.21
rno-miR-127 29.80 6 0.14 23.73 6 0.21 1.03 6 0.10
rno-miR-320 29.82 6 0.39 24.12 6 0.25 1.76 6 0.30
rno-miR-185 30.65 6 0.07 23.90 6 0.09 0.85 6 0.08
rno-miR-26a 30.79 6 0.44 25.42 6 0.18 1.13 6 0.22
rno-miR-541 30.92 6 0.29 24.60 6 0.06 1.15 6 0.07
rno-miR-103 31.09 6 0.33 24.58 6 0.03 1.00 6 0.15
rno-let-7c 31.25 6 0.25 24.86 6 0.05 1.09 6 0.11
rno-miR-221 31.41 6 0.33 25.38 6 0.18 1.41 6 0.02
rno-miR-382 31.46 6 0.18 26.21 6 0.07 1.90 6 0.15
rno-miR-16 31.53 6 0.31 26.12 6 0.12 2.16 6 0.15
aCT values are the average of three replicates (6SD).
bRelative expression as calculated by the comparative threshold
method (Schmittgen and Livak 2008), and as delineated in the
Materials and Methods section.
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miR-382, miR-24, and miR-185 (Table 4). Many of these
target genes coded for receptors and ion channels, molec-
ular motors, transcription and translation factors, ribo-
somal proteins, as well as proteins involved in vesicle
recycling. All of these putative target mRNAs have been
identified in the axons of invertebrates (Martin 2004;
Crispino et al. 2009) and vertebrates (Willis et al. 2007;
Taylor et al. 2009; Vogelaar et al. 2009). It is important to
note that receptors and transmembrane proteins can be
synthesized locally in axons (Spencer et al. 2000; Bi et al.
2006; Tsai et al. 2006) and that functional receptors appear
to be incorporated into the axolemma via an ER- and
Golgi-dependent mechanism (Merianda et al. 2009).
Although attention has been focused on miRNAs that are
relatively abundant or enriched in the axon in this report
(Table 1), it is likely that low abundance miRNAs might
also play an important role in the regulation of local trans-
lation and axonal function. For example, the axonal local-
ization of brain-specific miR-338 has been established by
in-situ hybridization histochemistry using LNA hybridiza-
tion probes, and has been shown to regulate axonal ATP
synthesis and respiration in SCG neurons through modu-
lation of COXIV mRNA levels (Aschrafi et al. 2008).
Protein translation in neurons occurs in the cell bodies
or locally in the distal neuronal processes. Local protein
synthesis is implicated in many aspects of neuronal de-
velopment and function, such as axon guidance, dendritic
elaboration, synaptic plasticity, and long-term memory
formation. Although the existence of local translation in
dendrites has been widely accepted, the question of whether
or not translation occurs in axons has remained more
controversial. Recent findings establish that proteins req-
uisite for structural/functional maintenance of axons are
synthesized locally in the axon and nerve terminal, and call
attention to the intimacy of the relationship that has
evolved between the distant cellular domains of the neuron
and its local protein synthetic system (for review, see
Kaplan et al. 2009).
In conclusion, our studies delineated the miRNAs pres-
ent in the axons of sympathetic neurons, and provide an
important resource for future studies on the role played by
miRNAs in the regulation of intra-axonal protein synthesis.
MATERIALS AND METHODS
Neuronal cell culture
SCG were obtained from 3-d-old Harlan Sprague Dawley rats,
and dissociated neurons plated in the central compartment of
FIGURE 3. Visualization of miRNAs in distal axons by in situ
hybridization (ISH). ISH was performed in primary SCG neurons at
7 d in vitro (DIV) using fluorescein isothiocyanate (FITC)-conjugated
LNA probes for miR-16 (A), miR-221 (B), and a scrambled miR probe
as a negative control (C). Arrows indicate the location of punctate
ISH signals in distal axons for miR-16 and miR-221. Scale bars,
10 mm. Phase contrast images of the axon fibers are provided in the
corresponding top panels.
TABLE 3. Overview of the ratios of intensities (axon/soma) for
polycistronically expressed miRNAsa
miRNA
Ratio
of intensities
(axon/soma)
miR-433-127 cluster
rno-miR-433 1.71 6 0.09
rno-miR-127 1.44 6 0.15
rno-miR-136 0.80 6 0.34*
miR-379-410 cluster
rno-miR-379 0.45 6 0.15
rno-miR-329 0.48 6 0.04
rno-miR-487b 0.64 6 0.11
rno-miR-539 0.67 6 0.13
rno-miR-382 0.85 6 0.12
rno-miR-134 1.64 6 0.33***
rno-miR-485 0.84 6 0.13
rno-miR-154 0.82 6 0.12
rno-miR-541 1.49 6 0.21***
miR-17-92 cluster
rno-miR-17 1.88 6 0.48
rno-miR-18a 0.50 6 0.50
rno-miR-20a 1.89 6 0.23
rno-miR-19b 1.26 6 0.32
rno-miR-92 2.80 6 0.89*
miR-99a/let-7c/miR-125b-2 cluster
rno-let-7c 1.45 6 0.09
rno-miR-99a 2.72 6 0.51**
rno-miR-125b 1.35 6 0.15
miR-106b-25 cluster
rno-miR-25 2.15 6 0.33**
rno-miR-93 0.85 6 0.18
One-way ANOVA and Tukey’s HSD post-hoc test were used to
calculate significant differences between the indicated miRNA(s)
and the remainder of the miRNAs within the same cluster: (*) P <
0.05; (**) P < 0.01; (***) P < 0.0001.
aData are the average of six replicates (6 SEM).
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TABLE 4. List of selected putative target genes for the abundant and/or enriched axonal miRNAs
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
rno-miR-204 (A/S ratio of intensity = 6.92 6 0.83)
Laminin receptor 1 (ribosomal protein SA)
LAMR1a,b NM_017138.1 Laminin receptor activity
Cell–cell adhesion
Discs, large homolog 5
DLG5a NM_001107247.1 Cell–cell adherens junction
Dynein, cytoplasmic, light chain 1
DNCLC1a NM_053319.2 Neurotransmitter metabolic process
Nitric oxide biosynthetic process
Glyoxylase 1
GLO1a NM_207594.1 Glutathione metabolic process
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
rno-miR-221 (A/S ratio of intensity = 5.83 6 0.49)
Tropomyosin 3, g
TPM3a NM_057208.2 Actin binding
Kinesin 2
KNS2a NM_001081973.1 Microtubule motor activity
Axon cargo transport
Glycoprotein M6A
GPM6a NM_178105.2 Calcium channel activity
Potassium large conductance calcium-activated channel, subfamily m, b
KCNMB4a NM_023960.2 Calcium-activated potassium channel activity
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
ADP rybosilation factor 4
ARF4b NM_024151.1 Epidermal growth factor receptor signaling
pathway
Small GTPase mediated signal transduction
Vesicle-mediated transport
rno-miR-146 (A/S ratio of intensity = 4.89 6 0.35)
Ribosomal protein L30
RPL30a,b NM_022699.2 Translation
Structural constituent of ribosome
Dynein, cytoplasmic, light chain 2A
DNCL2Aa NM_131910.3 Motor activity
Retrograde axon transport
Aldo-keto reductase family 1, member A1
AKR1A1a,b NM_031000.3 Alcohol dehydrogenase (NADP+) activity
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6
ATP5Ja NM_053602.1 Mitochondrial proton-transporting ATP synthase
complex, coupling factor F(o)
CUG triplet repeat, RNA binding protein 2
CUGBP2a NM_017197.2 mRNA processing
RNA binding
Syntaxin 7
STX7a NM_021869.2 Synaptic vesicle exocytosis
SNAP receptor activity
Casein kinase II, a 1 polypeptide
CSNK2A1a NM_053824.2 Wnt receptor signaling pathway
Protein phosphatase activity
Colony stimulating factor 1 receptor
CSF1Rb NM_001029901.1 Transmembrane receptor protein tyrosine kinase
signaling pathway
Protein tyrosine kinase activity
(continued )
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TABLE 4. Continued
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
Barrier to autointegration factor 1
BANF1b NM_053631.2 DNA binding
rno-miR-16/15b (A/S ratio of intensity = 3.69 6 0.35/2.90 6 0.39)
Ribosomal protein L32
RPL32a NM_013226.2 Translation
Structural constituent of ribosome
Tumor protein, translationally controlled 1
TPT1a NM_053867.1 Calcium ion binding
Ribosomal protein L41
RPL41a,b NM_139083.1 Translation
Structural constituent of ribosome
Kinesin familiy member 5A
KIF5Aa NM_212523.1 Microtubule motor activity
Heterogenous nuclear ribonucleoprotein A1
HNRPA1a,b NM_017248.1 mRNA transport
mRNA processing
Mitogen activated protein kinase 8 interacting protein
MAPK8IPa NM_053777.1 Regulation of JNK cascade
Kinesin binding
Glutamate receptor, ionotropic, N-methyl D-aspartate- Like 1A
GRINL1Aa NM_183402.1 Transcription
DNA-directed RNA polymerase activity
rno-miR-320 (A/S ratio of intensity = 2.29 6 0.24)
Ribosomal protein L15
RPL15a NM_139114.3 Translation
Structural constituent of ribosome
Catenin (cadherin associated protein), b 1, 88 kDa
CTNNB1a,b NM_053357.2 Regulation of transcription
Wnt receptor signaling pathway
Zinc finger protein 161
ZFP161a NM_172325.1 Zinc ion binding
Protein binding
Nucleic acid binding
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
Glutamate receptor, ionotropic, N-methyl D-aspartate- Like 1A
GRINL1Aa NM_183402.1 Transcription
DNA-directed RNA polymerase activity
CDK5 activator binding protein
CDK5RAP2b XM_575844.2 Neuronal Cdc2-like kinase binding
Tubulin, a 1A
TUBA1Ab NM_022298.1 Microtubule-based movement
GTPase activity
Peroxiredoxin 1
PRDX1b NM_057114.1 Cell redox homeostasis
Response to oxidatve stress
Enolase 1, a
ENO1b NM_012554.2 Glycolysis
Phosphopyruvate hydratase activity
Ubiquitin carboxy-terminal hydroxylase L1
UCHL1b NM_017237.2 Ubiquitin-dependent protein
catabolic process
Ubiquitin thiolesterase activity
(continued )
Natera-Naranjo et al.
1522 RNA, Vol. 16, No. 8
TABLE 4. Continued
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
rno-miR-103 (A/S ratio of intensity = 1.81 6 0.15)
Ribosomal protein L32
RPL32a NM_013226.2 Translation
Structural constituent of ribosome
Tropomyosin 3, g
TPM3a NM_057208.2 Actin binding
Kinesin family member 5A
KIF5Aa NM_212523.1 Microtubule motor activity
Kinesin complex
Mitogen activated protein kinase 8 interacting protein
MAPK8IPa NM_053777.1 Regulation of JNK cascade
Kinesin binding
Kinesin 2
KNS2a NM_001081973.1 Microtubule motor activity
Axon cargo transport
Adenylate kinase 2
AK2a NM_030986.1 Adenine metabolic process
Adenylate kinase activity
Glutathione peroxidase
GPX4a NM_017165.2 Phospholipid-hydroperoxide glutathione
peroxidase activity
Mitochondrial inner membrane
Syntaxin 7
STX7a NM_021869.2 Synaptic vesicle exocytosis
SNAP receptor activity
Golgi associated, g adaptin ear containing, ARF binding protein 3
GGA3a NM_001108304.1 Intracellular protein transport
Cyclin G associated kinase
GAKa NM_031030.1 Protein amino acid phosphorylation
Protein serine/threonine kinase activity
Phospolipase C, b 1
PLCB1a NM_001077641.1 Lipid catabolic process
Phosphoinositide phospholipase C activity
Phosphoric diester hydrolase activity
Cysteine-rich protein 2
CRIP2a NM_022501.1 Zinc ion binding
Metal ion binding
RAN, member RAS oncogene family
RANa NM_053439.1 Microtubule cytoskeleton organization
GTPase activity
Zinc finger protein 161
ZFP161a,b NM_172325.1 Zinc ion binding
Protein binding
Nucleic acid binding
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
Sterol regulatory element binding factor 2 (predicted)
SREBF2a NM_001033694.1 Positive regulation of transcription from RNA
polymerase II promoter
Steriod metabolic process
Response to hormone stimulus
Nuclear factor I/B
NFIBa NM_031566.1 Regulation of transcription, DNA dependent
Tubulin a A1
TUBA1Ab NM_022298.1 Microtubule-based movement
GTPase activity
(continued )
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TABLE 4. Continued
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
Cystatin 3
CST3b NM_012837.1 Response to axon injury
Positive regulation of DNA replication
Cysteine-type endopeptidase inhibitor activity
Ribosomal protein L41
RPL41b NM_139083.1 Translation
Structural constituent of ribosome
Calcium channel, voltage-dependent, L type, a 1C subunit
CACNA1Cb NM_012517.2 Calcium ion transport
Voltage-gated calcium channel activity
Calpain, small subunit 1
CAPNS1b NM_017118.1 Calcium ion binding
Calcium-dependent cysteine-type
endopeptidase activity
Thymus cell surface antigen
THY1b NM_012673.1 Negative regulation of axonogenesis
Positive regulation of peptidyl-tyrosine
phosphorylation
rno-miR-541 (A/S ratio of intensity = 1.49 6 0.21)
Arginase type II
ARG2a NM_019168.1 Arginine metabolic process
rno-miR-125b (A/S ratio of intensity = 1.35 6 0.15)
Golgi SNAP receptor member 1
GOSR1a NM_053584.2 Retrograde transport, endosome to golgi
ER to golgi vesicle mediated transport
SNAP receptor activity
Ubiquitin A-52 residue ribosomal protein fusion product 1
UBA52a,b NM_031687.3 Positive regulation of transcription
Stathmin-like 3
STMN3a NM_024346.1 Tubulin binding
Microtubule depolymerization
NADH dehydrogenase (ubiquinone) flavoprotein 3-like
NDUFV3La NM_001101011.2 Electron transport chain
Mitochondrial inner membrane
Dynein, cytoplasmic, light intermediate chain 1
DNCLI1a NM_145772.1 ATP binding
Motor activity
Zinc finger protein 161
ZFP161a,b NM_172325.1 Zinc ion binding
Protein binding
Nucleic acid binding
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
Casein kinase II, a 1 polypeptide
CSNK2A1a NM_053824.2 Wnt receptor signaling pathway
Protein phosphatase activity
rno-miR-23a,b (A/S ratio of intensity = 1.33 6 0.12/1.16 6 0.12)
Ribosomal protein S23
RPS23a,b NM_078617.2 Translation
Structural constituent of ribosome
Up-regulated during skeletal muscle growth 5
USMG5a NM_133544.1 Integral to membrane
Mitochondrion
(continued )
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TABLE 4. Continued
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
Tropomyosin 3, g
TPM3a NM_057208.2 Actin binding
Neural precursor cell expressed, developmentally down-regulated gene 8
NEDD8a NM_138878.2 Regulation of transcription from RNA
polymerase II promoter
Myristoylated alanine rich protein kinase C substrate
MARCKSa M59859.1 Calmodulin binding
Actin binding
Protein kinase C binding
CUG triplet repeat, RNA binding protein 2
CUGBP2a NM_017197.2 mRNA processing
RNA binding
MARCKS-like protein
MLPa NM_057144.1 Cellular calcium ion homeostasis
COMM domain containing 3
COMMD3a NM_198732.1 Protein binding
Basonuclin 2
BNC2a NM_001106666.1 DNA binding
Zinc-ion binding
Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
SLC25A4a NM_053515.1 Glutamate uptake
Transmembrane transport
Adenine nucleotide transmembrane
transport activity
CREB binding protein
CREBBPa NM_133381.2 Positive regulation of transcription from RNA
polymerase II promoter
Protein phosphatase 3, catalytic subunit, a isoform
PPP3CAa NM_017041.1 Regulation of synaptic transmission
Calcium ion transport
Phosphoprotein phosphatase activity
Zinc finger protein 161
ZFP161a,b NM_172325.1 Zinc ion binding
Protein binding
Nucleic acid binding
Katanin p60 subunit A-like 1
KATNAL1a NM_001006956.1 Microtubule-severing
ATPase activity
ATP binding
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
Casein kinase II, a 1 polypeptide
CSNK2A1a NM_053824.2 Wnt receptor signaling pathway
Protein phosphatase activity
Glutamate receptor, ionotropic, N-methyl D-aspartate- Like 1A
GRINL1Aa NM_183402.1 Transcription
DNA-directed RNA polymerase
activity
Neurofilament, light polypeptide
NEFLb NM_031783.1 Anterograde axon cargo transport
Retrograde axon cargo transport
Axon transport of mitochondria
Myosin regulatory light chain (RLC-B)
MRLC2b NM_017343.2 Motor activity
Calcium ion binding
(continued )
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TABLE 4. Continued
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
rno-miR-26a (A/S ratio of intensity = 1.24 6 0.06)
Catenin (cadherin associated protein), b 1, 88 kDa
CTNNB1a,b NM_053357.2 Regulation of transcription Wnt receptor
signaling pathway
Cytochrome c oxidase subunit VA
COX5Aa NM_145783.1 Cytochrome c oxidase activity
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, e polypeptide
YWHAE a NM_031603.1 Protein kinase C inhibitor activity
Microtubule associated protein 1B
MAP1ba,b NM_019217.1 Negative regulation of microtubule
depolymerization
Microtubule binding
Transmembrane emp24-like trafficking protein 10
TMED10b NM_053467.1 Intracellular protein transport
Vesicle mediated transport
rno-miR-382 (A/S ratio of intensity = 0.85 6 0.12)
Ribosomal protein L32
RPL32a NM_013226.2 Translation
Structural constituent of ribosome
Ribosomal protein S11
RPS11a,b NM_031110.1 Translation
Structural constituent of ribosome
ATP synthase, H+ transporting, mitochondrial F1 complex, g polypeptide 1
ATP5C1a,b NM_053825.1 Oxidative phosphorylation
ATP biosynthetic process
Proton-transporting ATPase activity,
rotational mechanism
Nerve growth factor receptor (TNFRS16) associated protein 1
NGFRAP1a NM_053401.1 Induction of apoptosis via death domain
receptors
Ribosomal protein S11
RPS11b NM_031110.1 Translation
Structural constituent of ribosome
Ribosomal protein L15
RPL15a,b NM_139114.3 Translation
Structural constituent of ribosome
rno-miR-24 (A/S ratio of intensity = 0.84 6 0.11)
Dynein, cytoplasmic, light intermediate chain 1
DNCLI1a NM_145772.1 ATP binding
Motor activity
Pyroglutamyl-peptidase 1
PGPEP1a NM_201988.2 Proteolysis
Cysteine-type peptidase activity
Parkinson disease 7
PARK7a NM_057143.1 Response to oxidative stress
Translocase of inner mitochondrial membrane 13 homolog
TIMM13a NM_145781.1 Protein import into mitochondrial inner
membrane
Transmembrane transport
Matrin 3
MATR3a NM_019149.2 RNA binding
Zinc ion binding
Churchill domain containing 1
CHURC1a NM_001106741.2 Positive regulation of transcription
(continued )
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Campenot compartmented culture dishes as previously described
(Hillefors et al. 2007). Cells were cultured in serum-free medium
containing 20 mM KCl, NGF (50 ng/mL), and 20 U/mL
Penicillin/20 mg/mL Streptomycin (Hyclone) for 3–10 d prior to
use, with media changes every 3–4 d. To inhibit the prolifera-
tion of nonneuronal cells, 5-fluoro-29-deoxyuridine (50 nM) was
added to the culture medium 24 h after plating and maintained
throughout the culture period. The side compartments, which
contained the distal axons used in these experiments, contained
no neuronal soma or non-neuronal cells, as judged by phase-
contrast microscopy, as well as ethidium bromide and acridine
orange staining.
Western blot analysis
Distal axons in the side compartments of Campenot chambers or
soma and proximal axons in the central compartment were
harvested separately and lysed in 50 mM Tris-HCl (pH 7.4),
TABLE 4. Continued
miRNA (A/S ratio of intensity)
Target gene
GO annotationAbbreviation Accession number
Glutamate receptor, ionotropic, N-methyl D-aspartate- Like 1A
GRINL1Aa NM_183402.1 Transcription
DNA-directed RNA polymerase activity
Sterol regulatory element binding factor 2 (predicted)
SREBF2a NM_001033694.1 Specific RNA polymerase II transcription
factor activity
Steriod metabolic process
Response to hormone stimulus
Neurofilament, medium polypeptide
NEFMb NM_017029.1 Neurofilament cytoskeleton organization
Axon cargo transport
rno-miR-185 (A/S ratio of intensity = 0.62 6 0.05)
Dynein, cytoplasmic, light chain 2A
DNCL2Aa NM_131910.3 Motor activity
Retrograde axon transport
ATPase, H+ transporting, V1 subunit F
ATP6V1Fa NM_053884.1 Proton transport
ATP synthesis coupled protein transport
ATPase activity, coupled to transmembrane
movement of ions
COP9 constitutive photomorphogenic homolog subunit 4
COPS4a NM_001004275.1 Protein binding
Cyclin G associated kinase
GAKa NM_031030.1 Protein amino acid phosphorylation
Protein serine/threonine kinase activity
Trans-2,3-enoyl-CoA reductase
GPSN2a NM_138549.1 Lipid biosynthetic process
Oxidoreductase activity
Cysteine-rich protein 2
CRIP2a NM_022501.1 Zinc ion binding
Metal ion binding
Glutamate receptor, ionotropic, N-methyl D-aspartate- Like 1A
GRINL1Aa NM_183402.1 Transcription
DNA-directed RNA polymerase activity
CD63 antigen
CD63b NM_017125.3 Positive regulation of cell adhesion
Positive regulation of endocytosis
Cytochrome b-245, b polypeptide
CYBBb NM_023965.1 Oxidation reduction
NAD(P)H oxidase activity
Barrier to autointegration factor 1
BANF1b NM_053631.2 DNA binding
Note: A/S indicates axon/soma.
aPresence of the mRNA in the axon previously reported by Taylor et al (2009).
bPresence of the mRNA in the axon previously reported by Willis et al (2007).
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150 mM NaCl, 1 mM EDTA, 1% NP-40, and Complete protease
inhibitor cocktail (Roche). Protein concentration was assessed
using the Micro BCA Protein Assay Kit (Pierce). For SDS-PAGE,
equal amounts (2–5 mg) of each lysate were boiled in NuPage
sample buffer (Invitrogen) and resolved on 4%–12% linear
gradient gels. Proteins were transferred to PVDF membranes,
probed with monoclonal antibodies to b-actin, Tau, and MAP2
(Sigma), and developed using the ECL Advance Western Blotting
Detection Kit (GE Health Care).
In situ hybridization
Visualization of miR-16 and miR-221 in the axons of SCG
neurons was accomplished by in situ hybridization using fluores-
cein isothiocyanate (FITC)-conjugated LNA probes (25 nM,
Exiqon). A scrambled miR probe was employed as a negative con-
trol. We followed the protocol described in Aschrafi et al. (2010),
with the following modifications. After fixation, the neurons were
dehydrated and rehydrated by sequential addition of 70%, 90%,
100%, 90%, and 70% ethanol solutions, and washed three times in
PBS. After hybridization, the neurons were washed twice in
23SSC and twice in 0.23SSC at 60°C, for 30 min each. The
signal intensity of the FITC probe was amplified with the Alexa
Fluor 488 Signal Amplification Kit (Molecular Probes).
RNA isolation and miRNA microarray analyses
Total RNA was isolated from the axons or soma of SCG neurons
using RiboZol RNA extraction reagent (Amresco) according to
the manufacturer’s protocol. The concentration and purity of the
RNA were assessed using a UV spectrophotometer. Total RNA
samples, isolated from the central and side compartments of the
Campenot chambers, were analyzed using the NCode Multi-
Species miRNA microarray kit (Invitrogen). MicroRNA popula-
tions were polyadenylated and subsequently ligated to labeled
DNA polymers using the 6X Alexa Fluor 3 (A3) or 6X Alexa Fluor
5 (A5) Rapid Ligation Mix. The two differentially labeled re-
actions were combined into one tube and then loaded onto
NCode Multi-Species miRNA Microarray V2. The arrays were
mounted with the Maui Mixer SL and hybridized overnight (16–
20 h) at 52°C with constant mixing. The arrays were washed and
scanned using a GenePix 4000B microarray scanner (Molecular
Devices). The scanned array images were then annotated and
analyzed using the GenePix software. The annotated data were
normalized using a Latin Squares algorithm by the NCode Profiler
data analysis software. A dye swap analysis was performed on the
data to identify differential markers. The array data were checked
to ensure the median backgrounds were below 75 relative fluo-
rescent units (RFU). Median local backgrounds were subtracted
from the median spot intensities to generate background-corrected
median intensities for all spots.
Quantitative RT-PCR
For optimized detection and quantification of miRNAs, cDNA
was synthesized from total RNA using the NCode miRNA First
Strand cDNA synthesis kit (Invitrogen) according to the manu-
facturer’s protocol. Using first-strand cDNA as a template, trip-
licate qPCR reactions were performed for each miRNA using
miRNA-specific forward primers and the NCode Universal qPCR
reverse primer. The forward primers for qPCR analyses for each
miRNA were designed using the entire mature miRNA sequence.
Minus template and minus forward primer controls were included
to ensure lack of signal in the assay background. All CT values used
for analyses were averaged from three to six replicates and those
with high standard deviation (>1) were not included in the anal-
yses. Melting curve analysis was performed to test for the specificity
and quality of the qPCR amplifications. Relative expression was
calculated using the comparative CT method and normalized to
the expression of U6 snRNA and miR-103. Using miR-221 as an
example, the relative expression (RQ) was calculated as follows:
DDCT =DCT;axon  DCT;soma = CT;miR-221  CT;U6
 
axon
 CT;miR-221  CT;U6
 
soma
= 31:41  29:45½ 
 25:39  23:97½ = 1:92  2:41 =  0:49;
where relative expression (or RQ) = 2DDCT = 2
(0.49) = 1.41.
RT-PCR methodology was also used to assess the purity of the
axonal RNA preparations. In these experiments, total RNA was re-
verse transcribed using oligo (dT) primers and SuperScript First-
Strand Synthesis Kit (Invitrogen). Amplification was accomplished
using gene-specific primers as previously described (Gioio et al. 2001).
PCR reactions for synaptic vesicle associated proteins and GFAP were
fractionated by electrophoresis on 2.5% agarose gels, and amplicons
were visualized by ethidium bromide staining. PCR reactions without
reverse transcriptase yielded no amplification products.
Statistical analysis
Student’s t-test was used to determine significant differences be-
tween two groups. One-way ANOVA and Tukey’s HSD post-hoc
test were used to analyze significant differences among multiple
groups; P < 0.05 was considered significant.
SUPPLEMENTAL MATERIAL
Supplemental material can be found at http://www.rnajournal.org.
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